Regeneron antibody cuts risk of COVID-19 death in UK study

Dive Brief: A major study found that Regeneron’s antibody treatment can reduce the risk of death for certain people hospitalized with COVID-19, the first definitive evidence a drug aimed at the coronavirus can lower mortality among the sickest patients.   Regeneron’s combination antibody regimen cut the risk of death by 20% in patients who had […]